Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 51.05 M51.1 M79.3 M63.88 M74.93 M 269.2 M Research & development ————— — Operating income -325.58 M81.02 M55.19 M45 M34.36 M 215.57 M Non-Operating Income, Total -160.42 M72.07 M85 M11.68 M17.95 M 186.7 M Interest expense, net of interest capitalized 344 K354 K193 K38 K64 K 649 K Non-Operating Income, excl. Interest Expenses -153.23 M70.72 M84.15 M11.07 M17.57 M 183.52 M Unusual income/expense -7.54 M993 K655 K575 K308 K 2.53 M Pretax income -486 M153.09 M140.18 M56.69 M52.31 M 402.26 M Equity in earnings ————— — Taxes -3.9 M-61.29 M6.78 M1.44 M4.09 M -48.99 M Non-controlling/minority interest ———-7 000-7 000 — After tax other income/expense -1.18 M-1.2 M-1.44 M-2.57 M-1.04 M -6.24 M Net income before discontinued operations -482.1 M214.38 M133.42 M55.25 M48.22 M 451.27 M Discontinued operations ————— — Net income -482.1 M214.38 M133.42 M55.25 M48.22 M 451.27 M Dilution adjustment 0-44.79 M109.58 M0— — Preferred dividends 0000— — Diluted net income available to common stockholders -482.1 M169.6 M243 M55.25 M48.22 M 516.07 M Basic earnings per share (Basic EPS) -4.480.933.110.230.19 4.46 Diluted earnings per share (Diluted EPS) -4.480.643.40.210.18 4.43 Average basic shares outstanding 107.51 M229.9 M158.7 M244.04 M248.18 M — Diluted shares outstanding 107.51 M266.68 M158.7 M266.69 M268.64 M — EBITDA 95.1 M551.22 M541.29 M477.17 M474.67 M 2.04 B EBIT 80.89 M528.22 M515.75 M450.4 M444.77 M 1.94 B Cost of revenue 470 K413 K884 K1.38 M2.06 M 4.73 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 14.21 M23 M25.54 M26.77 M29.9 M 105.2 M